Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%

Trials by Status

completed133%
terminated133%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
completed

Prevalence of Thrombosis in COVID-Patients

NCT04615026
unknown

Blood Flow Measurement Using Quantitative Magnetic Resonance Angiography and Duplex Sonography

NCT03591523
terminated

Cerebral Perfusion Monitoring With Transpharyngeal Ultrasonography

NCT01828411

Clinical Trials (3)

Showing 3 of 3 trials
NCT04615026

Prevalence of Thrombosis in COVID-Patients

Completed
NCT03591523

Blood Flow Measurement Using Quantitative Magnetic Resonance Angiography and Duplex Sonography

Unknown
NCT01828411

Cerebral Perfusion Monitoring With Transpharyngeal Ultrasonography

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3